Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) can specifically promote the division and proliferation of endothelial cells and the revascularization, finally induce angiopoiesis. Recently, VEGF-based gene therapy has been gradually used in clinical trials, but some limits on usually used vectors deserve further studies, including the low transfection efficiency of plasmid vector, the immunogenicity of adnovirus vector to host cells and the potential risk of infection. OBJECTIVE: To construct the non-pathogenic recombinant adeno-associated vires (AAV) co-expressing human vascular endethelial growth factor 165 (hVEGF165) and green fluorescent protein (GFP) label and measure the virus titer and assess its biological activity.DESIGN, TIME AND SETTING: The open experiment was performed at the Vitrus Laboratory of Shanxi Provincial Center for Disease Control and Prevention from March to September 2007.MATERIALS: AAV-293 virus packaging cell line, AAV HT-1080 cells were purchased from Swatagene, USA. E.coli DH5α was a stocked strain from Shanxi Provincial Center for Disease Control and Prevention. AAV Helper Free System (pAAV-IRES-GFP vector containing GFP label) was purchased from Stratagene, USA. Plasmid pUC18-hVEGF165 was constructed previously by Dr.Shi from Department of Orthopaedics of Second Affiliated Hospital of Xi'an Jiaotong University.METHODS: The hVEGF165 gone from plasmid pUC18-hVEGF165 was amplified and inserted into plasmid pAAV-IRES-hrGFP. Then recombinant plasmid pAAV-hVEGF165-IRES-hrGFP, pAAV-RC and pAAV-Helper were co-transfected into AAV-293 cells to complete rAAV-hVEGF165-IRES-hrGFP packaging through homologous recombination. The efficiency of A.AV packaging was monitored under a fluorescent microscope, and the recombinant viral particles were harvested from infected AAV-293 cells and further concentrated and purified. The recombinant virus infected the AAV-HT1080 cells, the virus titer was measured by fluorescence counting, and the recombinant AAV-hVEGF165-IRES-hrGFP was verified by the amplification of the exogenous gene of hVEGF165 from virus genome.MAIN OUTCOME MEASURES: Virus packaging efficiency was monitored under the fluorescence microscope. Virus filer was measured by fluorescent counting. The packaging of recombinant virus was determined by the amplification of the exogenous hVEGF165 gene.RESULTS: The amplified products were verified as hVEGF165 gene by DNA sequencing, and the recombinant pAAV-hVEGF165-IRES-hrGFP was confirmed by double digestion. The system provided a high packaging ratio of over 95% and the purified recombinant virus had a high titer of 5.5×1011 vp/mL. The recombinant virus was confirmed by exogenous human VEGF165 gene from virus genome.CONCLUSION: The non-pathogenic rAAV-hVEGF165-GFP simultaneously carrying hVEGF165 and GFP 1abel is successfully constructed, with a high titer and satisfying biological activity.

Construction of Recombinant Adenovirus Vector Containing Human ggpps Gene and Its Effect on Activation of HSCs

Construction and Identification of GGPPS Gene Interference Adenovirus

Enhanced Growth of Recombinant Human Adenovirus Type 41 (Hadv-41) Carrying ADP Gene

Construction and Expression of Recombinant Adenovirus Containing Human Thymic Stromal Lymphopoietin Gene

Construction of the recombinant adenovirus vectors containing human glutathione peroxidase gene

Establishment of A Recombinant Adeno-Associated Virus Expressing Hvegf(165)

[Construction of Lentivirus Vector Carrying HGF and Exploration of Transfection Condition of Rat Adipocyte-derived Mesenchymal Stem Cells].

Construction of Adenovirus Vector with Human Interleukin 10 and Its Expression in Vascular Smooth Muscle Cells

[Construction of Recombinant Adenovirus Vector of Calcitonin Gene-Related Peptide Gene and Transfection to Neonatal Rat Cardiomyocytes].

Reconstruction and Identification of Adenovirus Expression Vector for Human Transforming Growth Factor Β1

[Construction and Identification of Recombinant Adenovirus Expressing Rat Proteoglycan II].

[Tumor-Targeting Expression of a New Tumor Suppressor Gene HCCS1 and Its Tumor-Selective Inhibitory Effects on Hepatocellular Carcinoma].

Construction and identification of recombinant adenovirus vector with the fusion gene GC2A:GM-SCF and LMP2A

Construction of Recombinant Adeno-Associated Virus Vector Co-Expressing Hvegf165 and Hbmp7 Gene

Establishment of a Lentiviral vector encoding human HGF and the infection of human ADSCs

Construction and identification of recombinant adenovirus vector expressing human S100A8

Construction and Identification of Recombinant Adeno- Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor and Green Fluorescent Protein

Construction and Identification of Human Growth Arrest-Specific Homeobox Gene Recombinant Adenovirus

Construction and identification of recombinant adenovirus expressing hPDGF-A and hBD2

Construction of the Recombinant Human Endothelial Nitric Oxide Synthase Gene Adenovirus and Its Expression in Human Vascular Smooth Muscle Cells

Construction and Expression of Recombinant HBx-expressed Adenovirus and HBx Expression in HepG2